Latest News for: kyowa

Edit

35-YEAR INDUSTRY-ACADEMIC PARTNERSHIP YIELDING GROUNDBREAKING ADVANCES FOR SCIENCE AND PATIENTS RENEWS FOR ANOTHER THREE YEARS BETWEEN LA JOLLA INSTITUTE FOR IMMUNOLOGY AND KYOWA KIRIN

PR Newswire 04 Apr 2025
(Kyowa Kirin, TSE ... Simultaneously, Kyowa Kirin has evolved into a leading global specialty pharmaceutical company that develops novel therapies for patients with rare and debilitating diseases ... About Kyowa Kirin.
Edit

Systemic Sclerosis Market on Track for Major Expansion by 2034, According to DelveInsight | Kyowa ...

GetNews 02 Apr 2025
The Key Systemic Sclerosis Companies in the market include- Kyowa Hakko Kirin, ... Kyowa Hakko Kirin ... Kyowa Kirin Co., Ltd ... Kyowa Kirin submitted an sNDA for brodalumab in treating systemic sclerosis.
Edit

Shareholder Voting Result at the 102nd Ordinary General Meeting of Shareholders (Kyowa Kirin Co Ltd)

Public Technologies 21 Mar 2025
) ... [Cover page]. Document title.. Extraordinary Securities Report ... Filing date. ... (Kyowa Kirin Kabushiki Kaisha) ... Kyowa Kirin Co., Ltd ... 1 ... At the 102nd Ordinary General Meeting of Shareholders (the "Meeting") of Kyowa Kirin Co., Ltd ... Kyowa Kirin Co.
Edit

Notice of Resolutions of the 102nd Ordinary General Meeting of Shareholders (Kyowa Kirin Co Ltd)

Public Technologies 21 Mar 2025
). (Note) This document has been translated from the Japanese original for reference purposes only ... (Securities Code 4151). March 19, 2025. Dear Shareholders,. Abdul Mullick ... Kyowa Kirin Co., Ltd ... Kyowa Kirin Co., Ltd ... Notice. Matters Reported ... Kyowa Kirin Co.
  • 1
×